Gubra

Peptide discovery/obesity pipeline

GUBRA · Nasdaq Copenhagen · Denmark

Public Market Listing

GUBRANasdaq Copenhagen

Nasdaq Copenhagen primary exchange listing

Live quotes, historical charts, and market capitalization for Gubra are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Phase 2
GLP-1/GIP/NPY2 receptor (triple)Peptide
Obesity
Phase 1/2
Corticotropin-releasing factor receptor 2Peptide
Obesity

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
June 2027 (1)
BI 3034701Phase 2Obesity, Overweight
Est. primary completion 2027-06-26 · NCT07662122 · CT.gov ↗
What to watch
2028 (1)
December 2028 (1)
GUB-UCN2Phase 1/2Obesity, Type 2 Diabetes
Est. primary completion 2028-12 · NCT07702890 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

No financial reports recorded.